ArticleCureus2026
Spectrum of Upper Gastrointestinal Endoscopic Findings in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: A Single-Center Experience From Pakistan.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSymptoms related to the upper gastrointestinal (GI) tract and bleeding complications are common presentations in patients with end-stage renal disease (ESRD) receiving maintenance hemodialysis. Various factors, including uremia, platelet dysfunction, use of anticoagulation during hemodialysis, anemia, impaired GI motility, diabetes mellitus, and polypharmacy, can lead to a wide range of abnormalities. Local literature from Pakistan is scant. Therefore, the aim was to assess the spectrum of upper GI endoscopic findings in hemodialysis patients with ESRD.
methodsAfter approval from the ethical review committee at the Sindh Institute of Urology and Transplantation (SIUT), this prospective, descriptive cross-sectional study was conducted at the Department of Hepatogastroenterology, SIUT, Pakistan, between January 2024 and December 2024. Patients aged 18-65 years suffering from ESRD receiving maintenance hemodialysis for at least three months who had undergone upper GI endoscopy for dyspepsia, vomiting, reflux, anemia, hematemesis, melena, or pre-transplant assessment were included. Data regarding demographics, co-morbidities, dialysis factors, endoscopic indications, lab investigations, drug exposure, and endoscopic findings were collected.
resultsA total of 150 patients participated in the study. The mean age was 47.8 ± 13.6 years, and among them, 92 (61.3%) were males. Diabetes mellitus was found in 64 (42.7%) patients, while hypertension was found in 126 (84%) patients. The most common reason for performing the endoscopy was dyspepsia or epigastric pain in 58 (38.7%) patients, followed by anemia of undetermined cause in 35 (23.3%), and upper GI bleed in 27 (18%) patients, respectively. Endoscopic abnormalities were noted in 126 (84%) patients. The most common finding was gastritis in 76 (50.7%) patients, followed by erosive gastropathy in 42 (28.0%), reflux esophagitis in 31 (20.7%), duodenitis in 28 (18.7%), gastric ulcers in 16 (10.7%), and duodenal ulcers in 11 (7.3%) patients, respectively.
conclusionUpper GI lesions are common in patients with ESRD on hemodialysis therapy. The common abnormalities include gastritis, erosive gastropathy, esophagitis, duodenitis, and peptic ulcers. Endoscopic examination needs to be done early in patients with symptoms suggestive of upper GI problems. These findings support consideration of timely upper GI endoscopic evaluation in symptomatic patients with ESRD receiving maintenance hemodialysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.